List view / Grid view
26 October 2015 | By Victoria White
The collaboration will evaluate the use of CRISPR-Cas9 across multiple diseases, including cystic fibrosis, where targets have been validated through human genetics...
7 September 2015 | By Victoria White
Basilea is to work with the iABC consortium to develop an inhaled formulation of its antibiotic BAL30072 as part of a new Europe-wide programme...
2 September 2015 | By Victoria White
ESCMID advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms...
4 August 2015 | By Victoria White
Researchers have used nanoparticles to breach the human airway mucus barrier of lung tissue - a finding that could lead to effective drug delivery systems...
29 July 2015 | By Victoria White
CF microbes are able to survive in saliva and mucus that is chemically heterogeneous, including significant portions that are largely devoid of oxygen...
16 July 2015 | By Victoria White
Researchers have developed a user-friendly resource to accompany the powerful CRISPR/Cas9 tool, which has been widely adopted to make precise changes in DNA...
15 July 2015 | By Victoria White
Galapagos has entered into a licensing agreement with the HUB foundation for use of Organoid Technology for preclinical research in cystic fibrosis and IBD...
15 July 2015 | By Victoria White
Weizmann Institute scientists have shown how it might be possible to use embryonic stem cells to repair damaged lung tissue...
2 March 2015 | By MRC Technology
Project focused on potential small molecule or antibody targets in pathways important in the development or progression of respiratory disease...
